FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a ...
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a ...
Private equity’s investments in ophthalmology are entering a new, more ...
The first quarter of 2022 delivered eleven reported ophthalmology practice acquisitions, marking a sharp decline from the flurry of closings at the end of last year This was expected as business development teams had exhausted all resources toward closing deals last quarter We will highlight a few notable deals.